ketamine-assisted psychotherapy
with contributions by Psychedelic Institute fellows, Michael DeMarco, PhD and Thaís Salles Araujo, MD on ketamine, psilocybin mushrooms in palliative care
at home ketamine therapy
"The deployment of mesoscale brain-wide fluctuation analysis unveils the complex, multiregional neural orchestration underlying ketamine’s rapid antidepressant effects, a blueprint for future therapeutic innovation... insights gained from this research hold transformative promise..."
hallucinogen rating scale
On the the Hallucinogen Rating Scale (HRS), a widely used tool for measuring subjective effects of psychedelics and other psychoactive substances and real-world ketamine assisted therapy practice data
denver ketamine therapist
Licensed Addiction & Clinical Mental Health Counselor, Ketamine-Assisted Psychotherapy, Telehealth, Denver, Detroit, Telehealth Psychedelic-Assisted Therapist, NeurOptimal® Neurofeedback Trainer
at home ketamine
Over 800 posts to date! See what's new in ongoing ketamine research spanning over 60 years.
michael demarco therapist
Collaborative psychotherapy in support of medicines that may affect mental health, including ketamine
cbt
There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate therapeutic alliance, including, but not limited to telehealth.
psychedelic therapy
An evolving overview of cognitive behavioral therapy in psychedelic-assisted psychotherapy and ketamine psychedelic therapy.
at-home ketamine
Psychedelic and psychiatric medicines have been studied for over 100 years as adjuncts to psychotherapy, with over 60 years of ongoing research on the off-label use of racemic ketamine, a generic medicine in various routes of administration with varying levels of support care
ketamine-assisted psychotherapy
"A systematic review of PO and SL ketamine noted no significant side effects, and no problems with tolerance or substance misuse in any of the studies, which totaled 140 patients who received ketamine up to 3 years in duration…” (Swainson, 2022)